Aktis Oncology (AKTS) Balance Sheet: Assets & Liabilities

Aktis Oncology (AKTS) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Aktis Oncology reported total assets of $264.88M and total liabilities of $77.63M. Shareholders' equity was $187.26M. Total debt stood at $11.55M against $226.79M in cash and short-term investments, a net cash position of $215.24M. That puts debt-to-equity at 0.06.

Aktis Oncology Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Aktis Oncology, Inc. (AKTS) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022
Current Assets
Cash and Cash Equivalents	37.78	37.16	29.51	128.60
Short-Term Investments	189.00	260.01	68.35	0.00
Cash & Short-Term Investments	226.79	297.17	97.86	128.60
Accounts Receivable	1.10	0.00	0.30	0.00
Inventory	0.00	0.00	0.00	0.00
Other Current Assets	3.52	3.69	2.34	3.88
Total Current Assets	230.31	300.85	100.20	132.48
Non-Current Assets
Property, Plant & Equipment (Net)	27.25	20.87	20.92	4.87
Other Non-Current Assets	7.33	4.46	1.23	0.98
Total Non-Current Assets	34.58	25.33	22.15	5.84
Total Assets	264.89	326.18	122.36	138.32
Current Liabilities
Accounts Payable	1.74	1.92	0.96	0.49
Short-Term Debt	1.32	1.30	1.53	0.85
Accrued Liabilities	9.52	3.25	3.75	2.74
Deferred Revenue	18.66	9.28	0.00	0.00
Other Current Liabilities	9.52	6.33	3.75	3.93
Total Current Liabilities	31.24	18.82	6.24	5.28
Non-Current Liabilities
Long-Term Debt	10.23	10.71	11.87	0.92
Other Non-Current Liabilities	36.16	333.41	0.50	0.01
Total Non-Current Liabilities	46.39	395.16	12.37	152.28
Total Liabilities	77.63	413.98	18.61	157.55
Stockholders' Equity
Retained Earnings	-156.56	-92.83	-48.85	-20.21
Accumulated Other Comprehensive Income	0.04	0.12	0.08	0.00
Additional Paid-in Capital	10.37	4.91	2.47	0.98
Shares Outstanding	52.52	52.52	52.52	52.52
Total Stockholders' Equity	187.26	-87.80	103.74	-19.23
Total Liabilities & Equity	264.89	326.18	122.36	138.32

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Aktis Oncology Balance Sheet

How much debt does Aktis Oncology have?

Aktis Oncology had total debt of $11.55M as of Dec 31, 2025, against $226.79M in cash and short-term investments. Its debt-to-equity ratio was 0.06. Total debt was $12.01M a year earlier.

What are Aktis Oncology's total assets?

Aktis Oncology reported total assets of $264.88M as of Dec 31, 2025, down 18.8% from $326.18M a year earlier. Total liabilities were $77.63M.

What is Aktis Oncology's shareholders' equity?

Aktis Oncology's shareholders' equity was $187.26M as of Dec 31, 2025, or about $3.57 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition